NCT ID | NCT02278120 |
Title | Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer |
Recruitment | Active, not recruiting |
Gender | female |
Phase | Phase III |
Variant Requirements | yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |